Highly Sensitive Photonic Crystal Fiber Biosensor Based on Surface Plasmon Resonance for Six Distinct Types of Cancer Detection

AbstractAn innovative photonic crystal fiber (PCF) biosensor using surface plasmon resonance (SPR) to diagnose six distinct kinds of cancers (skin cancer, cervical cancer, adrenal gland cancer, blood cancer, and breast cancer types 1 and 2) in cells is demonstrated here and incorporates with two microchannels and a bimetallic configuration. The numerical analysis utilizes the finite element method (FEM) combined with perfectly matched layers (PML). The plasmonic material employed in the biosensor is gold (Au), and a supportive material, titanium dioxide (TiO2), is combined with Au. By combining these two materials, the sensor ’s performance is improved. The numerical calculations indicate that breast cancer type 2 has the highest wavelength sensitivity (24,285.71 nm/RIU) and amplitude sensitivity (3959 RIU−1). The rest of the cancer cells ’ wavelength sensitivities are 11,000.00 nm/RIU (skin cancer), 13,333.33 nm/RIU (cervical cancer), 15,000.00 nm/RIU (blood cancer), 17,142.85 nm/RIU (adrenal gland cancer), and 21,428.57 nm/RIU (breast cancer type 1). This advanced biosensor has several uses in biological sensing and medical techn ology, and it has the potential to revolutionize cancer identification and medical diagnosis.
Source: Plasmonics - Category: Biomedical Science Source Type: research